Ginger Liau is a partner on the Bio + Health team focused on biotech. She leads business development for the a16z life sciences portfolio, specializing in research collaborations to advance novel modalities and platform technologies. Ginger joined a16z in 2019 after completing her MBA at Stanford. Prior to that, she worked at Alnylam Pharmaceuticals where she held a variety of positions across the business. She was an RNA chemist before moving into strategy, program management, and investor relations roles.